Combined sales for the top 50 US chemical companies declined 21% to $247.5 billion in 2009, reflecting the impact of the recession. Only four firms recorded revenue increases. The companies with the highest sales were Dow Chemical, Exxon Mobil, DuPont and PPG Industries, which recorded 2009 revenue changes of -22.0%, -30.1%, -14.6%, -18.3%, respectively. Sales […]
According to Food Processing magazine’s 39th Annual R&D Survey, which questioned 310 food manufacturers, R&D remains a priority. Half of those surveyed chose “new product development” as the most important target for their companies’ R&D efforts this year, followed by “existing product improvement,” which was selected by 13% of respondents. Food safety and nutrition are […]
Following the 2008 recession and heightened scrutiny over executive rewards, there is little surprise that total executive compensation for the executives in IBO’s annual executive compensation tables declined last year. In fiscal 2009, total average compensation for the 57 executives at 42 analytical instrument and laboratory product companies in IBO’s three Stock Indexes (see IBO […]
The gloom has lifted, according to the latest results of IBO’s Business Climate Survey. In contrast to the fall 2009 Business Climate Survey, conducted in October 2009 (see IBO 10/15/09), when 17% of respondents expected sales to decline in the next six months, not one Survey participant in this spring’s Survey expects sales to decline. […]
In aggregate, US, European, Canadian and Australian biotech companies recorded a $3.7 billion net profit in 2009, making it the first profitable year for the industry. However, raising capital remained difficult, with a few established companies gaining the bulk of new capital. Capital raised by US biotech firms rose 39% to $18.0 billion. Revenues for […]
Industrial emissions in the US are not being accurately recorded due to outdated monitoring equipment. Although recommendations have been made to the EPA to adopt more advanced monitoring equipment, such as the types used in Europe, the EPA has no plans to implement them. A 2006 report by the EPA inspector general found that emissions […]
IMS Healthcare Insight is maintaining its forecast of 4%–6% growth in pharmaceutical sales this year. Slower growth due to patent expirations and government cost mandates will be offset by growth in emerging markets. Over the next five years, patents will expire for products with sales of more than $142 billion. Drug sales are forecasted to […]
The food and beverage industry’s capital spending is expected to increase 19.3% this year, according to a survey of 32 public companies. In 2009, these companies’ capital spending fell 8.7%. Twenty-four of the 32 firms project increases in capital spending this year, led by PepsiCo and Tyson Foods. Spending plans include greenfield projects, which are […]
Instrument companies appear to be gearing up to expand their microarray offerings into regulated markets. So far this year, three companies have made announcements regarding FDA 510(k) submissions of their cytogenetic microarray products. And just this week, PerkinElmer purchased a provider of clinical cytogenetic microarray testing services (see page 2). The news illustrates the rapid […]
In a year destabilized by capital constraints, lower R&D spending and order delays, a new leader emerged as the largest provider of analytical and life science instruments and aftermarket products, based on IBO’s annual calculation. Life Technologies, which resulted from the merger between Invitrogen and Applied Biosystems (see IBO 6/15/08), further expanded its leadership in […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
